On target: Genetically modified cells show promise in targeted immunotherapy for advanced blood cancers

Author： Printz Carrie  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|7|929-930

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.7, 2014-04, pp. : 929-930

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Genetically Modified Dendritic Cells for Cancer Immunotherapy

By  

Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. : 619-628

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotherapy of Human Cancers Using Gene Modified T Lymphocytes

By  

Current Gene Therapy, Vol. 9, Iss. 5, 2009-10 ,pp. : 396-408

Bentham Science Publishers

Access to resources Recommend Favorite

Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 15, Iss. 5, 2015-01 ,pp. : 394-405

Bentham Science Publishers

Access to resources Recommend Favorite

Safety Strategies of Genetically Engineered T Cells in Cancer Immunotherapy

By  

Current Pharmaceutical Design, Vol. 24, Iss. 1, 2018-03 ,pp. : 78-83

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer Immunotherapy Using Gene-Modified Dendritic Cells

By  

Current Gene Therapy, Vol. 2, Iss. 1, 2002-02 ,pp. : 57-78

Bentham Science Publishers

Access to resources Recommend Favorite